![Barry Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry Simon
Directeur/Membre du Conseil chez
IMMUNITYBIO, INC.
Fortune : 21 M $ au 31/05/2026
Profil
Barry J. Simon occupe le poste de président du conseil d'administration, président et chef de la direction de Brink Biologics, Inc. et celui de directeur et chef des affaires générales de ImmunityBio, Inc. Il est également membre du conseil d'administration de Cue Biopharma, Inc. (ancien président) et de Viracta Therapeutics, Inc. Dans le passé, le Dr Simon a occupé le poste de vice-président de Roche Holding AG et de vice-président de Roche Diagnostics Corp. (filiale de Roche Holding AG), vice-président de HealthPro BioVentures LLC, vice-président de North Sound Capital LLC, vice-président des affaires cliniques et réglementaires d'iTherX Pharmaceuticals, Inc. et président, directeur et directeur administratif de NantKwest, Inc. et vice-président d'Immunomedics, Inc. Le Dr Simon a obtenu un doctorat de l'Université d'État de New York au Downstate Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNITYBIO INC 0,27 % | 04/06/2026 | 2 827 788 ( 0,27 % ) | 21 M $ | 31/05/2026 |
Postes actifs de Barry Simon
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNITYBIO, INC. | Directeur/Membre du Conseil | 01/01/2007 |
Brink Biologics, Inc.
 Brink Biologics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | 01/03/2015 |
Anciens postes connus de Barry Simon
| Sociétés | Poste | Fin |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/12/2024 |
| CUE BIOPHARMA, INC. | Président | - |
| IMMUNITYBIO, INC. | Directeur Général | 01/03/2015 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Directeur/Membre du Conseil | 01/11/2020 |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Corporate Officer/Principal | 01/12/2004 |
Formation de Barry Simon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
iTherX Pharmaceuticals, Inc.
 iTherX Pharmaceuticals, Inc. Medical DistributorsDistribution Services Engages in the discovery and development of drugs and therapies | Distribution Services |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
HealthPro BioVentures LLC
 HealthPro BioVentures LLC Investment ManagersFinance HealthPro BioVentures serves the biotechnology, biomedical, healthcare and pharmaceutical sectors. Their purpose is to define, enhance and realize value for their clients by leveraging their experience, resources and network of relationships. The firm seeks to provide unparalleled services to meet the needs of the life sciences sector, from large corporate entities to emerging companies. HealthPro originally emerged from DavosPharma. They draw on extensive contacts through their relationships and association with DavosPharma. As a result, HealthPro has a network of both buy-side and sell-side healthcare opportunities. HealthPro BioVentures' services include the development of strategic and tactical themes and target lists of potential partners, access to their vast, proprietary library of available compounds, assisting with presentations and due diligence dossiers, analysis of the synergies of potential strategic partners, advising on structure, timing and pricing of transactions and assisting with negotiation, documentation and closing of transactions. HealthPro targets potential partners and investors to assist both public and private companies who are looking to acquire a strategic target company or product. The firm's portfolio of services allows them to represent life sciences companies that are either interested in being acquired or interested in investing specific assets. In both by-side and sell-side transactions, their focus is on developing transactions that are mutually beneficial to both the buyer and the seller. | Finance |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Sound Capital LLC
 North Sound Capital LLC Investment ManagersFinance North Sound is a global long/short equity hedge fund manager. Though not limited by sector, they tend to focus on large-cap companies in the finance, communications, retail, energy and consumer services sectors. | Finance |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Brink Biologics, Inc.
Brink Biologics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
ImmunityBio, Inc.
 ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
Roche Labs |
